---
title: "AI HealthTech Biorce Opens U.S. Offices in Austin to Accelerate Global Expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281897553.md"
description: "AI healthtech company Biorce is opening a new office in Austin, Texas, to enhance its global expansion efforts. Founded in Barcelona, Biorce has already established a presence in New York and aims to build an AI healthtech hub in Austin, attracting talent and expanding its R&D team. The company recently secured over $52 million in a Series A funding round, the largest in Spain or Portugal, and received the 4YFN26 Award for its innovation. CEO Pedro Coelho emphasizes a science-first approach to AI in clinical trials."
datetime: "2026-04-07T14:23:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281897553.md)
  - [en](https://longbridge.com/en/news/281897553.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281897553.md)
generator: "portal-rs"
---

# AI HealthTech Biorce Opens U.S. Offices in Austin to Accelerate Global Expansion

**AUSTIN, Tex. —** 

***Austin, Texas, United States - \[April 7, 2026\]*** - AI healthtech pioneer Biorce is opening a second office in the United States this month in Austin, Texas, at the landmark address of 515 Congress Ave. The healthcare platform already has an office in New York.

The company was founded in Barcelona by a Portuguese founding team, with several members of the leadership team relocating to Texas. Biorce has received significant venture capital backing and has quickly risen to become one of the **most prominent AI healthtech startups in Europe**. In January 2026, Biorce secured the largest Series A round ever raised in Spain or Portugal, totaling more than $52 million.

The new offices in Austin represent a strategic move to expand the company’s R&D team and build an **AI healthtech hub in Texas**. Austin is an attractive location for talent. Biorce is actively hiring and plans to continue growing its team of AI engineers as well as other departments.

*“The expansion to Austin reflects our commitment to building a global center for AI-driven clinical trial innovation,”* said **Pedro Coelho**, founder and CEO of Biorce. *“We understand the challenges in global clinical development. Our platform brings together harmonized data, controlled input layers, and scalable AI models to solve some of the most complex problems in end to end clinical trials.”* 

Earlier this month, the company received the prestigious **4YFN26** **Award** at the world’s largest, influential **Mobile World Congress**, recognizing its rapid growth and technological innovation. Biorce’s founding team emphasizes a science-first approach to AI innovation. *“We are a mixture of true scientists and technologists building technology,”* said Coelho. *“That perspective shapes everything we build.”*

Contact us to learn more or book a demo.

### Related Stocks

- [BIOR.US](https://longbridge.com/en/quote/BIOR.US.md)

## Related News & Research

- [Why Wolfe Research Just Named Nvidia Stock Its Top AI Pick](https://longbridge.com/en/news/296822517.md)
- [What does Europe’s AI lag mean for the region?](https://longbridge.com/en/news/296510589.md)
- [Consulting's race to become AI native](https://longbridge.com/en/news/296676838.md)
- [Intapp partners with Legora to bring governed AI workflows to law firms](https://longbridge.com/en/news/296892415.md)
- [A mysterious free AI model is impressing developers. And nobody knows who made it.](https://longbridge.com/en/news/296687985.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**